11 years ago

Arcis Secures £1.7 Million for Antimicrobial Technologies

  • Arcis, a UK-based R&D company developing new technologies for durable antimicrobial applications, raised £1.7 million in funding

  • Calculus Capital invested £1.25 million in the round, following previous investments totaling £2 million

  • The company will use the funds to develop its business in DNA extraction and nematicide products.

      • ProblemAgriculture

      "Microscopic worms, called nematodes, attack the root systems of plants, causing them to grow poorly and reduce crop yields, resulting in significant financial losses for farmers."

      Solution

      "Arcis develops nematicides, a type of pesticide that effectively kills nematodes, protecting crops and ensuring healthy growth, leading to increased yields and reduced financial losses for farmers. They also provide DNA extraction products used for molecular diagnostics."

      Covered on